122 related articles for article (PubMed ID: 28528720)
1. In vivo dosimetry in gynecological applications-A feasibility study.
Van Gellekom MPR; Canters RAM; Dankers FJWM; Loopstra A; van der Steen-Banasik EM; Haverkort MAD
Brachytherapy; 2018; 17(1):146-153. PubMed ID: 28528720
[TBL] [Abstract][Full Text] [Related]
2. In vivo dosimetry for gynaecological brachytherapy using a novel position sensitive radiation detector: feasibility study.
Reniers B; Landry G; Eichner R; Hallil A; Verhaegen F
Med Phys; 2012 Apr; 39(4):1925-35. PubMed ID: 22482614
[TBL] [Abstract][Full Text] [Related]
3. Design and testing of a phantom and instrumented gynecological applicator based on GaN dosimeter for use in high dose rate brachytherapy quality assurance.
Guiral P; Ribouton J; Jalade P; Wang R; Galvan JM; Lu GN; Pittet P; Rivoire A; Gindraux L
Med Phys; 2016 Sep; 43(9):5240. PubMed ID: 27587055
[TBL] [Abstract][Full Text] [Related]
4. Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy.
Andersen CE; Nielsen SK; Lindegaard JC; Tanderup K
Med Phys; 2009 Nov; 36(11):5033-43. PubMed ID: 19994514
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of role of interstitial brachytherapy using template (MUPIT) in locally advanced gynecological malignancies.
Nandwani PK; Vyas RK; Neema JP; Suryanarayan UK; Bhavsar DC; Jani KR
J Cancer Res Ther; 2007; 3(2):111-5. PubMed ID: 17998736
[TBL] [Abstract][Full Text] [Related]
6. In vivo measurements for high dose rate brachytherapy with optically stimulated luminescent dosimeters.
Sharma R; Jursinic PA
Med Phys; 2013 Jul; 40(7):071730. PubMed ID: 23822434
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of linear array MOSFET detectors for in vivo dosimetry to measure rectal dose in HDR brachytherapy.
Haughey A; Coalter G; Mugabe K
Australas Phys Eng Sci Med; 2011 Sep; 34(3):361-6. PubMed ID: 21710233
[TBL] [Abstract][Full Text] [Related]
8. Comparison and uncertainty evaluation of different calibration protocols and ionization chambers for low-energy surface brachytherapy dosimetry.
Candela-Juan C; Vijande J; García-Martínez T; Niatsetski Y; Nauta G; Schuurman J; Ouhib Z; Ballester F; Perez-Calatayud J
Med Phys; 2015 Aug; 42(8):4954-64. PubMed ID: 26233221
[TBL] [Abstract][Full Text] [Related]
9. In vivo dosimetry of high-dose-rate interstitial brachytherapy in the pelvic region: use of a radiophotoluminescence glass dosimeter for measurement of 1004 points in 66 patients with pelvic malignancy.
Nose T; Koizumi M; Yoshida K; Nishiyama K; Sasaki J; Ohnishi T; Kozuka T; Gomi K; Oguchi M; Sumida I; Takahashi Y; Ito A; Yamashita T
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):626-33. PubMed ID: 18164870
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of a 2D diode array in "magic phantom" for use in high dose rate brachytherapy pretreatment quality assurance.
Espinoza A; Petasecca M; Fuduli I; Howie A; Bucci J; Corde S; Jackson M; Lerch ML; Rosenfeld AB
Med Phys; 2015 Feb; 42(2):663-673. PubMed ID: 28102606
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of MOSkin dosimeters to rectal wall in vivo dosimetry in gynecological HDR brachytherapy.
Carrara M; Romanyukha A; Tenconi C; Mazzeo D; Cerrotta A; Borroni M; Cutajar D; Petasecca M; Lerch M; Bucci J; Richetti A; Presilla S; Fallai C; Gambarini G; Pignoli E; Rosenfeld A
Phys Med; 2017 Sep; 41():5-12. PubMed ID: 28499627
[TBL] [Abstract][Full Text] [Related]
12. Verification of the plan dosimetry for high dose rate brachytherapy using metal-oxide-semiconductor field effect transistor detectors.
Qi ZY; Deng XW; Huang SM; Lu J; Lerch M; Cutajar D; Rosenfeld A
Med Phys; 2007 Jun; 34(6):2007-13. PubMed ID: 17654904
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of artifacts and distortions of titanium applicators on 3.0-Tesla MRI: feasibility of titanium applicators in MRI-guided brachytherapy for gynecological cancer.
Kim Y; Muruganandham M; Modrick JM; Bayouth JE
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):947-55. PubMed ID: 20934275
[TBL] [Abstract][Full Text] [Related]
14. Anthropomorphic phantom to investigate the bladder dose in gynecological high-dose-rate brachytherapy.
Silva RM; Belinato W; Macedo LE; Souza DN
Brachytherapy; 2015; 14(5):633-41. PubMed ID: 26077382
[TBL] [Abstract][Full Text] [Related]
15. Characterization of microMOSFET detectors for in vivo dosimetry in high-dose-rate brachytherapy with
Ruiz-Arrebola S; Fabregat-Borrás R; Rodríguez E; Fernández-Montes M; Pérez-Macho M; Ferri M; García A; Cardenal J; Pacheco MT; Anchuelo J; Tornero-López AM; Prada PJ; Guirado D
Med Phys; 2020 Jun; 47(5):2242-2253. PubMed ID: 32031263
[TBL] [Abstract][Full Text] [Related]
16. Dosimetry of ruthenium-106 ophthalmic applicators with thin layer thermoluminescence dosimeters - Clinical quality control.
Krause F; Möller M; Risske F; Siebert FA
Z Med Phys; 2020 May; 30(2):142-147. PubMed ID: 31818650
[TBL] [Abstract][Full Text] [Related]
17. A disposable OSL dosimeter for in vivo measurement of rectum dose during brachytherapy.
Hayashi H; Kimoto N; Maeda T; Tomita E; Asahara T; Goto S; Kanazawa Y; Shitakubo Y; Sakuragawa K; Ikushima H; Okazaki T; Hashizume T
Med Phys; 2021 Aug; 48(8):4621-4635. PubMed ID: 33760234
[TBL] [Abstract][Full Text] [Related]
18. A skin dose prediction model based on in vivo dosimetry and ultrasound skin bridge measurements during intraoperative breast radiation therapy.
Brodin NP; Mehta KJ; Basavatia A; Goddard LC; Fox JL; Feldman SM; McEvoy MP; Tomé WA
Brachytherapy; 2019; 18(5):720-726. PubMed ID: 31229364
[TBL] [Abstract][Full Text] [Related]
19. Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion.
Kertzscher G; Andersen CE; Siebert FA; Nielsen SK; Lindegaard JC; Tanderup K
Radiother Oncol; 2011 Sep; 100(3):456-62. PubMed ID: 21963285
[TBL] [Abstract][Full Text] [Related]
20. A prototype open-ended multichannel intracavitary-interstitial hybrid applicator for gynecological high-dose-rate brachytherapy.
Tien CJ; Chen ZJ
Radiol Phys Technol; 2020 Jun; 13(2):187-194. PubMed ID: 32424632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
